Background Basal cell carcinoma (BCC) is the most common skin cancer in the Caucasian population. Eighty per cent
Introduction
Basal cell carcinoma (BCC) is a locally destructive and rarely metastasizing non-melanoma skin cancer (NMSC), which comprises 40% of all cancers worldwide. 1 Eighty per cent of NMSCs are BCCs. 2 The incidence of BCC is as high as the incidence of all other cancers combined, and its incidence continues to increase, also affecting ever-younger populations. [3] [4] [5] BCC is causing a remarkable burden via healthcare costs, treatment capacity and the morbidity of affected individuals. 1, 2, 4 Histologically, BCCs can be classified by their morphological growth pattern into indolent (nodular and superficial) or BBCs, the punch biopsy fails to identify the subtype correctly compared to the following excision, and 11-14.1% of any type of BCC shows an unsuspected aggressive component in the excision compared to the preceding punch biopsy. 8, 11 The incidence of BCC is highest in the most sun-exposed anatomic locations. 12 Thus, 80% of BCCs -and most of the aggressive types -are located on the head and neck area, 2, 13 where preserving the anatomy and function plays a major role. Surgery and, if available, Mohs micrographic surgery (MMS) with a 100% margin control are the treatment of choice for high-risk BCCs. 9 Hyperspectral imaging is based on tissue chromophores (like melanin if present, haemoglobin, proteins and water) affecting the absorption and scattering of emitted light, thus causing, together with autofluorescence, a unique spectral graph for different biological tissues.
14 A hyperspectral imaging system (HIS) has shown potential in the preoperative delineation of lentigo maligna 15 and the detection of field-cancerized skin. 16 In this pilot study, the aim was to test the feasibility of HIS in the preoperative delineation of the lateral margins of ill-defined BCCs on the head and neck area.
Materials and methods
We followed the Declaration of Helsinki, and the Ethics Committee of the Tampere University Hospital District, Finland, approved our study protocol. All the recruited volunteering patients were informed orally and in writing, and they provided their written consent.
Patients
Twenty-three patients with 24 lesions were recruited prospectively between March 2014 and March 2017 at the Department of Dermatology and Allergology at the Joint Authority for P€ aij€ at-H€ ame Health and Wellbeing, Lahti, Finland. The inclusion criterion was a clinically assessed primary BCC with a visually ill-defined margin on the head and neck area, which was later histologically confirmed to be a BCC. Eight
BCCs from seven patients were excluded: six because these were not treated according to the study protocol (3 represented only the superficial subtype and were treated with cryosurgery, and 3 were operated on without a separate circumferential marginal strip). Furthermore, one patient was excluded due to the imaging artefacts and one due to discrepancy in the histopathological statement (subclinical extension shown only in the preoperative biopsies and not in the separate margin strip). Thus, 16 patients (7 female and 9 male) with 16 lesions completed the study. The mean age of the patients was 77 years (range 59-91 years). Five patients displayed anamnestic skin phototype I, nine patients displayed skin phototype II, and two patients displayed skin phototype III. Thirteen patients had a previous history of skin malignancy or its precursor, and seven of them had multiple conditions (basal cell carcinoma n = 12, actinic keratosis n = 8 and melanoma n = 2). None of the patients had received cytostatics or radiotherapy in the study areas or received phototherapy for any skin condition. One patient had received immunosuppressive treatments.
Imaging processes
All the lesions were initially evaluated clinically and with a dermatoscope (Dermlite â 3GenCA, USA). They were photographed native with a digital camera (Canon Ixus 115 HS, 12.1 megapixel or Canon Ixus 130, 14.1 megapixel) and with the dermatoscope linked to the digital camera. The hyperspectral imaging process was performed initially without drawing the clinically assessed tumour border and then after marking the clinical borders on the skin. The prototype of HIS is described more detailed elsewhere. 15 (In short, the VTT FPI VIS-VNIR Spectral Camera uses visible-to-near-infrared light -i.e. wavelengths 500-900 nm based on a Fabry-Perot interferometer -which enables the use of tunable waveband selection. It has a large, 12 cm 2 field of view (FOV) with a spatial resolution of 6400 pixels/cm 2 , where one pixel is approx. 125 lm, and an imaging depth of approx. 2 mm.) 15 The hyperspectral imaging took only seconds to capture the hyperspectral data cube, which thereafter was analysed computationally in 5-10 min.
Data analysis
The hyperspectral data cube is a three-dimensional data cube, where the x-axis and y-axis are the dimensions on the skin surface, and the z-axis is the 70-layered hyperspectral images, where every layer is imaged on a narrow waveband. Every pixel on the skin's surface has a unique hyperspectral graph -i.e. an endmember -from which the abundance maps are calculated based on mathematical modelling (see Fig. 1 ).
In this pilot study, we used mathematical modelling of linear mixture, as used in our previous studies. 15, 16 These abundance maps were interpreted on site by the test readers (M.S., M.G., I.P. and N.N.). Additionally, we developed three diverse enhanced mathematical models to create more sensitive ways to characterize the visually ill-defined margins of BCCs. Finally, the mathematical models used for the results were (i) an inversion of linear mixture model using iterative vertex component analysis -i.e. the linear mixture (the one used on site), (ii) an inversion of linear mixture model from the estimated single scattering albedo (SSA) using iterative vertex component analysisi.e. the linear mixture with SSA, (iii) a closed form chromophore-specific approximation for the estimated SSA -i.e. chromophore specific with SSA and (iv) a modified standard normal variate correction algorithm -i.e. a standard variate. All abundance maps from these four models were interpreted by the same test readers. A summarized technical and mathematical presentation of the imaging system used, the algorithms and simulated results are presented in the Appendix S1. Each of the mathematical models used has advantages and disadvantages. The standard variate model is quite sensitive to all changes in spectra that differ from the mean spectra of the imaged area. When there is either a lot of normal skin or an illdefined BCC, the standard variate model will distinguish the areas well. The linear mixture and linear mixture with SSA both capture changes in the concentration of skin chromophores. The chromophore specific with SSA is sensitive to skin scattering and absorption. The results from calculations with the linear mixture, the linear mixture with SSA and the chromophore specific with SSA models can be used to simulate an imaged spectral cube. The simulated cube is a characterization of the originally acquired image presented in the form of an abundance map for interpretation.
Surgical procedures and the histopathological sampling
After the imaging and analysis processes, and if the patient did not have an appointment for an operation on the same day, we took biopsies from the lesions and the areas where the HIS imaging indicated the BCC may be spreading. For all cases, we used a special operation technique to verify whether a subclinical extension was detected by HIS (see Fig. 1 ). This included an initial excision of the tumour from the clinically and dermatoscopically detected border followed by a separately operated 2 mm circumferential marginal strip, both with orientation marks. The circumferential strip allowed us to evaluate whether there was a subclinical extension in the marginal area. If a free margin was found in the separately excised tumour specimen, this allowed us to evaluate whether the BCC was smaller than the clinical evaluation with dermatoscopy. All the samples were orientated, fixed in 10% formalin, embedded in paraffin and cut into 3-lmthick slices, which were stained with haematoxylin and eosin and, if necessary, with CK-PAN staining for the evaluation of perineural involvement. The tumour specimens were sectioned using the normal 'bread-loaf' technique. The circumferential strips were sectioned closely in vertical slices. The histopathological samples were analysed by an experienced dermatopathologist blinded to the HIS outcome. If the circumferential marginal strip was BCC-positive, a re-excision was performed.
Results
The histopathological subtypes of the 16 included BCCs are shown in Table 1 Delineating BCC with Hyperspectral Imaging System morpheaform or micronodular features) in the final excision. In 6 of 16 BCCs, the subtype was nodular, superficial or a mixed histology of these two in the final excision, even though clinically all the included lesions were ill-defined. In 12 of 16 cases, HIS was capable of delineating the BCCs more accurately than the conventional clinical evaluation by the naked eye and with a dermatoscope. HIS-delineated lesions were wider in 4 of 16 of the BCCs (see Fig. 2 ), and in 8 of 16 BCCs, the lesions were delineated to be smaller than the clinical evaluation. In 2 of 16 cases, the HIS-delineated lesion was wider but could not be confirmed histopathologically (false positives). In 2 of 16 cases, HIS did not detect the histopathologically confirmed BCC in the circumferential strip (false negatives).
The results were quite similar in the four different mathematical models. If three of four models showed similar tumour borders, those were regarded as the HIS-defined borders (see Table 1 ). However, it is still unclear which model is best for the imaging of BCC.
Discussion
This study shows that HIS is feasible in detecting the borders of ill-defined BCCs, but further development work is needed to determine the optimal model for data processing.
To our knowledge, there are no earlier studies on delineating BCC margins using hyperspectral imaging technology.
Other non-invasive imaging techniques for delineating the lateral margins of BCCs include dermatoscopy, reflectance confocal microscopy (RCM) and optical coherence tomography (OCT)/high-definition optical coherence tomography (HD-OCT). In clinical practice, dermatoscopy is the most widely used for the detection of lateral margins, although its use preoperatively has not reduced the excision stages in MMS, and thus, evidence of its accuracy is lacking. 17 It has been previously shown that preoperative in vivo use of RCM and OCT can reduce the number of excision stages in the MMS of BCCs. 17 The advantages of HIS compared to the previously studied imaging techniques in the preoperative assessment of the lateral surgical margin are the following: (i) adjustable FOV up to a maximum of 12 17 and 0.2-2.5 mm for OCT, although one should note that the higher resolution is compromised by the penetration depth 19 ; and (iii) interpretation of HIS images is quick, easy to learn with a little experience and does not require histological knowledge, unlike HD-OCT and RCM. 17, 19 It seems that the interpretation of HIS images can be straightforward, but currently in some cases more combined information is needed from different models to conclude the interpretation, and thus, further development of HIS is warranted. †HIS delineated the lesion smaller than clinical assessment, and histopathology supported this. ‡HIS delineated the lesion wider than the clinical assessment, and the histopathology supported this. §HIS showed no suspicious for subclinical extension, but in the histopathology there was BCC in the circumferential strip.
(+) interpret wider in the abundance maps (À) interpret smaller in the abundance maps (0) too much of artefact for interpretation (=) interpreted as same borders as visually assessed (the margins announced in the tumour specimen were from 0 to 0.9 mm)
Our result for 4 of 16 BCCs revealed that subclinical extension by HIS is quite similar to RCM in the preoperative in vivo assessment of the margins, as in Venturini et al.'s 20 study, RCM found subclinical extension in 3 of 10 cases compared to the dermatoscopically assessed margins prior to excision. OCT found the subclinical extension of BCC in 11 of 52 cases compared to clinical evaluation by a Mohs surgeon. 21 Wang et al. 21 had a 100% evaluation of the margins in MMS excision compared to our design with vertical sections, which is clearly a limitation in our study. Furthermore, OCT delineated the lateral margins to be smaller by 1.4 AE 1.3 mm than the clinical evaluation. 21 HIS delineated the lesion as being smaller in 8 of 16 cases. In addition, high-frequency ultrasound (HFUS) and fluorescence diagnosis have earlier been studied for the in vivo preoperative delineation of BCC. In lateral margin delineation, ultrasound has a low correlation compared to histopathology. 22 The subclinical extensions of the infiltrative and micronodular subtypes of BCC in particular are less likely to be detected by HFUS. 23 In deep margin assessment, the correlation using HFUS is intermediate, 22 and in facial BCCs, there is even a good correlation for the deep margin with histopathology. 24 HFUS has the advantage of showing underlying structures like cartilage and bone. 24 In the fluorescence diagnosis of facial BCCs, the exogenic fluorescence diagnosis has no benefit in margin assessment compared to clinical evaluation in high-risk areas (though most of the BCCs were nodular in this study), 25 but in aggressive types, bispectral fluorescence imaging (using autogenic and exogenic fluorescence) had some potential in delineating the margins of BCC, with a 42% agreement in lateral margin assessment compared to the histopathology of MMS.
26
A limitation of HIS is its poorer resolution compared to OCT and RCM. In this study, HIS was not used to evaluate the deep margin, which in the future might be possible with further developments given the approx. 2 mm penetration depth of HIS. However, the assessment of deep margins is also limited with RCM and HD-OCT. 17 Artefacts in HIS abundance maps can be caused by an uneven imaging surface -i.e. round and sharp forms in the imaging area, and thus, one case locating on nose was excluded with low quality in the abundance maps for interpretation. With further developments of HIS, it might be possible to handle these artefacts better. Additional pathological findings (i.e. actinic keratoses, etc.) in the imaging area might also be confounding factors in the interpretation of the HIS abundance maps, and thus, further development work with HIS is needed. The limitations in our pilot study design were the small number of the cases, and thus, these results are preliminary. This study was not performed to distinguish BCCs from other lesions on sun-damaged skin, but rather to visualize the borders of the lesions. Thus, larger studies are warranted in the future. Subclinical extension in aggressive BCCs can consist of cords with a thickness of a few cells. 6 Thus, in the future it would be interesting to repeat this study design by assessing 100% of the margin and comparing the results to MMS. At the clinic where patients were recruited, MMS is not available, and thus, we used the presented operation technique. Compared to MMS, in our method the separate circumferential strip was not assessed with a 100% margin control. In one true-positive case, we were able to confirm subclinical extension of the marginal strip after additional histological sectioning based on the suspected subclinical extension in the HIS abundance maps. However, additional sectioning failed to reveal the subclinical extension in the two other false-positive cases. It can be speculated that MMS with a 100% margin control would have revealed the histological extension in these false-positive cases. It would be interesting to investigate whether HIS could be useful in MMS by reducing the number of stages by defining the margins preoperatively more accurately than the clinical evaluation and by being faster than RCM. HIS might be also useful in reducing the number of re-excisions by more accurate preoperative assessment in intermediate-or low-risk anatomic locations, and also in high-risk areas if MMS is not available. After MMS, primary BCCs have a 4.4% recurrence and recurrent BCCs have a 3.9% recurrence in the 10-year follow-up; after traditional excision, the corresponding rates are 12.2% and 13.5%. 27 In traditional excision, the recurrence rates vary according to the width of the surgical margin, where a 2, 3, 4 or 5 mm announced negative margin has a recurrence rate of 3.96%, 2.56%, 1.62% and 0.39%, respectively; if a positive margin is announced, the overall recurrence is 27%. 28 In the future with HIS, it might be possible to save tissues in cosmetically sensitive areas.
With the increasing incidence of BCCs, there is a need for new technologies to make the treatment of BCC less time-consuming and more cost-effective. With preliminary results of 12 of 16 more precisely delineated lesions and 4 of 16 revealed subclinical extensions, the HIS has the potential to be a clinical aid in treatment of ill-defined BCCs in the cosmetically sensitive areas of the head and neck region.
